|
Glenmark Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
70979.51 Cr.
|
P/BV
|
6.46
|
Book Value (Rs.)
|
389.58
|
|
52 Week High/Low (Rs.)
|
2538/1793
|
FV/ML
|
1/1
|
P/E(X)
|
52.12
|
|
Bookclosure
|
31/08/2026
|
EPS (Rs.)
|
48.25
|
Div Yield (%)
|
0.20
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 1984.75 | 1399.21 | 36.50 | 868.45 | 1441.25 |
| | | | | | |
| Net CashFlow From Operating Activities | 3445.03 | -827.60 | -265.44 | 625.39 | 1108.65 |
| Net Cash Used In Investing Activities | -1283.23 | 2.09 | 4560.89 | -528.49 | -333.28 |
| Net Cash Used From Financing Activities | -2708.75 | 787.05 | -3906.13 | -77.46 | -520.49 |
| Foreign Exchange Gains / Losses | 45.96 | 55.89 | 17.68 | 12.39 | 17.55 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.00 | 0.00 | -191.76 | 0.67 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -501.00 | 17.44 | 215.24 | 32.50 | 272.43 |
| Cash And Cash Equivalents Begin of Year | 1675.71 | 1658.27 | 1443.03 | 1410.53 | 1138.10 |
| Cash And Cash Equivalents End Of Year | 1174.71 | 1675.71 | 1658.27 | 1443.03 | 1410.53 |
